- Home
- SAVA vs TSQ Comparison
SAVA vs TSQ Comparison
Compare SAVA & TSQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAVA
- TSQ
- Stock Information
- Founded
- SAVA 1998
- TSQ 1996
- Country
- SAVA United States
- TSQ United States
- Employees
- SAVA N/A
- TSQ N/A
- Industry
- SAVA Biotechnology: Pharmaceutical Preparations
- TSQ Broadcasting
- Sector
- SAVA Health Care
- TSQ Consumer Discretionary
- Exchange
- SAVA Nasdaq
- TSQ Nasdaq
- Market Cap
- SAVA 134.2M
- TSQ 157.8M
- IPO Year
- SAVA N/A
- TSQ 2000
- Fundamental
- Price
- SAVA $2.59
- TSQ $9.91
- Analyst Decision
- SAVA Buy
- TSQ Strong Buy
- Analyst Count
- SAVA 3
- TSQ 3
- Target Price
- SAVA $111.50
- TSQ $16.83
- AVG Volume (30 Days)
- SAVA 12.4M
- TSQ 64.2K
- Earning Date
- SAVA 11-07-2024
- TSQ 11-07-2024
- Dividend Yield
- SAVA N/A
- TSQ 8.09%
- EPS Growth
- SAVA N/A
- TSQ N/A
- EPS
- SAVA N/A
- TSQ N/A
- Revenue
- SAVA N/A
- TSQ $447,955,000.00
- Revenue This Year
- SAVA N/A
- TSQ N/A
- Revenue Next Year
- SAVA N/A
- TSQ $0.24
- P/E Ratio
- SAVA N/A
- TSQ N/A
- Revenue Growth
- SAVA N/A
- TSQ N/A
- 52 Week Low
- SAVA $2.55
- TSQ $9.49
- 52 Week High
- SAVA $42.20
- TSQ $13.57
- Technical
- Relative Strength Index (RSI)
- SAVA 23.06
- TSQ 45.62
- Support Level
- SAVA $2.78
- TSQ $9.70
- Resistance Level
- SAVA $3.28
- TSQ $10.25
- Average True Range (ATR)
- SAVA 0.24
- TSQ 0.30
- MACD
- SAVA 0.40
- TSQ -0.03
- Stochastic Oscillator
- SAVA 4.73
- TSQ 26.12
About SAVA Cassava Sciences Inc.
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia.
About TSQ Townsquare Media Inc.
Townsquare Media Inc is a radio, digital media, entertainment, and digital marketing solutions company principally focused on being the premier local advertising and marketing solutions platform in small and mid-sized markets across the United States. It has three segments which are Subscription Digital Marketing Solutions, Digital Advertising, and Broadcast Advertising. It earns the majority of the revenue from the Broadcasting Advertising segment, which includes its local, regional, and national advertising products and solutions delivered via terrestrial radio broadcast. Its portfolio includes local media brands such as WYRK.com, WJON.com, and NJ101.5.com, and premier national music brands such as XXLmag.com, TasteofCountry.com, UltimateClassicRock.com, and Loudwire.com.